Putting Ireland at the forefront of medicine development for children
Interview: Gilead's Daniel O'Day on new medicines, winning the Covid battle and the search for cancer cures
Interview: Gilead's Daniel O'Day on new medicines, winning the Covid battle and the search for cancer cures
Docklands site will run clinical trials for paediatric versions of current and future drugs
High-tech loos could help monitor our health – but also share our private information
Developer pre-lets 25,000sq ft warehouse to US pharma giant Bio-Techne Corporation
Season 4 review: Elisabeth Moss is the best thing about an only occasionally gripping series
Cantillon: Balancing costs of research and needs of poorer countries is a challenge
US life sciences giant signs up for 51,288sq ft Crane House in advance of Q4 completion
Iseq moves into positive territory on upbeat corporate news
A more apt title for new reality show Don’t Rock the Boat would be Celebrity S**t in a Bucket
SHV Energy acquires majority stake in Charleville-headquartered company
Significant blow to hopes of identifying existing medicines to treat disease
Acute shortages reported in number of countries because of difficulties with stocks from US
Drug would be among first treatments for milder cases
Situation causes concerns that this could indicate start of Europe-wide shortage
President was granted access to REGN-COV2 following a compassionate-use request
Market Beat: With M&A activity busy, competition authorities need to be on their toes
Speculative development follows 250,000sq ft of letting activity within the past 12 months
World round-up: China reports new infections as Greece announces record daily number of cases
€63m contract covers 30,000 patients with severe Covid-19 symptoms in Europe
Dublin closes higher as banks bounce back and CRH, Ryanair and Dalata all gain
Company to invest €7m as it also establishes paediatric centre of excellence here
The world would be a worse place without globalisation, says the 58-year-old German
Alert comes after US secures Covid-19 drug treatment for next three months
UN agency ends treatment after results show little or no reduction in mortality
Scale of scientific endeavour is unprecedented with more than 145 candidates in development
Fears of shortages after maker of remdesivir pledges most output to US for next three months
Immunologist says US may struggle to achieve herd immunity even if a vaccine is developed due to prevailing scepticism
EMA committee recommends drug’s use in adults and adolescents from 12 years of age
Warning as Texas, Florida and Arizona all report biggest one-day increases in cases
Shares dip as it emerges there are no active talks on what would be politically sensitive deal
Approval would allow sale of drug in bloc for one year before all data on effects known
On a potential vaccine: ‘the air is thick with absurd promissory notes and dates of delivery’
Stocks soar on promising news remdesivir an effective treatment for virus
Drugs company has about 50,000 courses of remdesivir ready to distribute in the US
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices